Enhancement of antifungal activity by integrin-targeting of branched histidine rich peptides.
J Drug Target
; 22(6): 536-42, 2014 Jul.
Article
em En
| MEDLINE
| ID: mdl-24731059
The treatment of invasive candidiasis associated with growing numbers of immunocompromised patients remains a major challenge complicated by increasing drug resistance. A novel class of branched histidine-lysine (bHK) peptides has promising antifungal activity, and exhibits a mechanism similar to natural histatins, and thus may avoid drug resistance. The present studies evaluate ligand targeting of bHK peptides to fungal surface integrins by determining whether a cyclic RGD (cRGD) peptide with a large PEG linker could enhance bHK peptide antifungal activity. Whereas conjugates containing only the PEG linker reduced bHK peptide activity, conjugates with the cRGD-PEG ligand resulted in marked enhancement of activity against Candida albicans. This study provides the first demonstration of benefit from ligand targeting of antifungal agents to fungal surface receptors.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Peptídeos
/
Integrinas
/
Sistemas de Liberação de Medicamentos
/
Histidina
/
Antifúngicos
Idioma:
En
Revista:
J Drug Target
Ano de publicação:
2014
Tipo de documento:
Article